19
Sep
2022
Blog
News & Views
Search
6
Sep
2022
Bionest
Potential Game Changers in Diabetes and Obesity
Is metformin on the way out as a first-line therapy for type 2 diabetes, to be replaced by tirzepatide? We examine new treatments for diabetes and obesity.
22
Aug
2022
Bionest
Telehealth – Here to Stay, But Challenges to Growth Remain
The pandemic has changed the way many people access healthcare, with virtual services soaring. Is #telehealth here to stay? What challenges remain?
25
Jul
2022
Bionest
Big Tech’s Foray in Healthcare
By bringing its unique strengths to specific health problems, can Big Tech play a larger role in many facets of healthcare?
20
Jun
2022
Bionest
New EU Preparedness and Response Agency, HERA, Capitalizes on Lessons from the COVID-19 Pandemic 
Will the EU's new European Health Emergency Preparedness & Response Authority (HERA), successfully improve pandemic-preparedness & mitigate drug shortages?
6
Jun
2022
Bionest
NIH’s All of Us Project Achieves Key Milestone
The NIH launched the All of Us project in 2015 with the ambitious goal of building a database of fully sequenced genomes from at least 1m Americans. How has it fared so far?
23
May
2022
Bionest
New CheckPoint Inhibitor Therapeutic Approved, More on the Way
What effect will the introduction of Opdualag’s fixed-dose combination have on the future of checkpoint inhibitor development and approvals?
9
May
2022
Bionest
Moving Towards a Unified EU Health Policy – Beating Cancer Report Approved
The European Parliament's Beating Cancer (BECA) report addresses cancer prevention, diagnosis & treatment, with an emphasis on ensuring equitable access to quality care and support for cancer survivors and their families.
25
Apr
2022
Bionest
Biosimilars on the Rise, Spurring Company Integration and Consolidation
From one to 34: Biosimilars are on the rise. How will it affect the pharmaceutical market for companies and consumers?
11
Apr
2022